ArticleLeukemia2023

Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemia.

Satoshi Yoshimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.